Clueless? Duan Yongping got caught buying Moderna at the peak.
Duan Yongping, the legendary investor widely known as "Da Dao Wu Xing Wo You Xing" on Investment Platform, has reportedly suffered a major loss on $Moderna, Inc.(MRNA)$, the recent star of U.S. biotech stocks.
He first built a position in MRNA back in 2021, when the stock was trading near its peak, and even posted on Investment Platform about his interest in the name. He added to his position multiple times afterward, but eventually liquidated his entire holding at $28.5 per share. Based on rough estimates, Duan lost nearly $24 million on this investment, with a staggering -60% return.
Even a top-tier investor can stumble outside his circle of competence. Does his recent avoidance of tech stocks suggest a limited grasp of the sector, which is why he sticks to consumer names like $POP MART(09992)$, $PDD Holdings Inc(PDD)$, and Kweichow Moutai?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- funzee·08-20 15:13Peak-era MRNA buyers were everywhere, not just him. Biotech can humble anyone fast when valuation, trial data, and pipeline assumptions all break at once.LikeReport
- MatthewWalter·08-20 15:13Top investors missing outside their circle is normal, not proof they are clueless. One biotech miss says less than a whole record built on consumer namesLikeReport